Navinta RX
FDA Approved Drugs

Navinta RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 22
  • Latest Approval Date Apr 23, 2026
  • Data Source FDA
  • First Approval Date Mar 06, 2008
All
26
View
Unclassified
1
View
Discontinued
3
View
RX
22
View
Company Overview

Company

Navinta RX

Country

U.S.A

Website

Visit Website

Email

sales@navinta.com

Social Profiles

Company Snapshot

Navinta RX

1499 Lower Ferry Road Ewing, NJ 08618

U.S.A

www.navinta.com/ sales@navinta.com View on Map
FDA Approved Drug Records ( 22 records )
2013
05 Feb
RX Application: 91525

Drug Name

BENZTROPINE MESYLATE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2013-02-05

91525 / 1

Active Ingredient

BENZTROPINE MESYLATE

Application Number

91525

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2013-02-05

Regulatory Status

RX

2022
22 Jun
RX Application: 213395

Drug Name

CARGLUMIC ACID

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2022-06-22

213395 / 1

Active Ingredient

CARGLUMIC ACID

Application Number

213395

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2022-06-22

Regulatory Status

RX

2018
11 Sep
RX Application: 210179

Drug Name

CARMUSTINE

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2018-09-11

210179 / 1

Active Ingredient

CARMUSTINE

Application Number

210179

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2018-09-11

Regulatory Status

RX

2025
14 Nov
RX Application: 217468

Drug Name

DIAZEPAM

Product Number

1

Dosage Form

-

Strength

2.5MG/0.5ML (5MG/ML)

Approval Date

2025-11-14

217468 / 1

Active Ingredient

DIAZEPAM

Application Number

217468

Product Number

1

Dosage Form

-

Strength

2.5MG/0.5ML (5MG/ML)

Approval Date

2025-11-14

Regulatory Status

RX

2025
14 Nov
RX Application: 217468

Drug Name

DIAZEPAM

Product Number

2

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

2025-11-14

217468 / 2

Active Ingredient

DIAZEPAM

Application Number

217468

Product Number

2

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

2025-11-14

Regulatory Status

RX

2025
14 Nov
RX Application: 217468

Drug Name

DIAZEPAM

Product Number

3

Dosage Form

-

Strength

20MG/4ML (5MG/ML)

Approval Date

2025-11-14

217468 / 3

Active Ingredient

DIAZEPAM

Application Number

217468

Product Number

3

Dosage Form

-

Strength

20MG/4ML (5MG/ML)

Approval Date

2025-11-14

Regulatory Status

RX

2010
27 May
RX Application: 91020

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2010-05-27

91020 / 1

Active Ingredient

FAMOTIDINE

Application Number

91020

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2010-05-27

Regulatory Status

RX

2008
06 Mar
RX Application: 78537

Drug Name

FOMEPIZOLE

Product Number

1

Dosage Form

-

Strength

1.5GM/1.5ML (1GM/ML)

Approval Date

2008-03-06

78537 / 1

Active Ingredient

FOMEPIZOLE

Application Number

78537

Product Number

1

Dosage Form

-

Strength

1.5GM/1.5ML (1GM/ML)

Approval Date

2008-03-06

Regulatory Status

RX

2026
23 Apr
RX Application: 220568

Drug Name

GLYCEROL PHENYLBUTYRATE

Product Number

1

Dosage Form

-

Strength

1.1GM/ML

Approval Date

2026-04-23

220568 / 1

Active Ingredient

GLYCEROL PHENYLBUTYRATE

Application Number

220568

Product Number

1

Dosage Form

-

Strength

1.1GM/ML

Approval Date

2026-04-23

Regulatory Status

RX

2013
28 Mar
RX Application: 202938

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2013-03-28

202938 / 1

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

202938

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2013-03-28

Regulatory Status

RX

2025
13 May
RX Application: 217880

Drug Name

MARAVIROC

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-05-13

217880 / 1

Active Ingredient

MARAVIROC

Application Number

217880

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-05-13

Regulatory Status

RX

2025
13 May
RX Application: 217880

Drug Name

MARAVIROC

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-05-13

217880 / 2

Active Ingredient

MARAVIROC

Application Number

217880

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-05-13

Regulatory Status

RX

2025
14 Mar
RX Application: 219111

Drug Name

MIGLUSTAT

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-03-14

219111 / 1

Active Ingredient

MIGLUSTAT

Application Number

219111

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-03-14

Regulatory Status

RX

2021
08 Oct
RX Application: 214363

Drug Name

PENICILLAMINE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2021-10-08

214363 / 1

Active Ingredient

PENICILLAMINE

Application Number

214363

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2021-10-08

Regulatory Status

RX

2014
17 Jul
RX Application: 78601

Drug Name

ROPIVACAINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

150MG/30ML (5MG/ML)

Approval Date

2014-07-17

78601 / 2

Active Ingredient

ROPIVACAINE HYDROCHLORIDE

Application Number

78601

Product Number

2

Dosage Form

-

Strength

150MG/30ML (5MG/ML)

Approval Date

2014-07-17

Regulatory Status

RX

2014
17 Jul
RX Application: 78601

Drug Name

ROPIVACAINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2014-07-17

78601 / 3

Active Ingredient

ROPIVACAINE HYDROCHLORIDE

Application Number

78601

Product Number

3

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2014-07-17

Regulatory Status

RX

2025
27 Oct
RX Application: 219931

Drug Name

SEVELAMER CARBONATE

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

2025-10-27

219931 / 1

Active Ingredient

SEVELAMER CARBONATE

Application Number

219931

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

2025-10-27

Regulatory Status

RX

2025
03 Feb
RX Application: 218966

Drug Name

SEVELAMER HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

2025-02-03

218966 / 1

Active Ingredient

SEVELAMER HYDROCHLORIDE

Application Number

218966

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

2025-02-03

Regulatory Status

RX

2016
04 Aug
RX Application: 205880

Drug Name

SODIUM PHENYLACETATE AND SODIUM BENZOATE

Product Number

1

Dosage Form

-

Strength

10%;10% (5GM/50ML;5GM/50ML)

Approval Date

2016-08-04

205880 / 1

Active Ingredient

SODIUM BENZOATE; SODIUM PHENYLACETATE

Application Number

205880

Product Number

1

Dosage Form

-

Strength

10%;10% (5GM/50ML;5GM/50ML)

Approval Date

2016-08-04

Regulatory Status

RX

2023
14 Jul
RX Application: 217526

Drug Name

SODIUM PHENYLACETATE AND SODIUM BENZOATE

Product Number

1

Dosage Form

-

Strength

10%;10% (2GM/20ML; 2GM/20ML)

Approval Date

2023-07-14

217526 / 1

Active Ingredient

SODIUM BENZOATE; SODIUM PHENYLACETATE

Application Number

217526

Product Number

1

Dosage Form

-

Strength

10%;10% (2GM/20ML; 2GM/20ML)

Approval Date

2023-07-14

Regulatory Status

RX

2026
17 Feb
RX Application: 220418

Drug Name

SODIUM PHENYLBUTYRATE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2026-02-17

220418 / 1

Active Ingredient

SODIUM PHENYLBUTYRATE

Application Number

220418

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2026-02-17

Regulatory Status

RX

2019
16 Jan
RX Application: 211251

Drug Name

TRIENTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-01-16

211251 / 1

Active Ingredient

TRIENTINE HYDROCHLORIDE

Application Number

211251

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-01-16

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    1 View
  • FDA Approved Drugs Database
    26 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
22 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BENZTROPINE MESYLATE

Application Number

91525

Product Number

1

Active Ingredient

BENZTROPINE MESYLATE

Dosage Form

-

Strength

1MG/ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit